GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Zhejiang Taimei Medical Technology Co Ltd (HKSE:02576) » Definitions » ROIC %

Zhejiang Taimei Medical Technology Co (HKSE:02576) ROIC % : 0.00% (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Zhejiang Taimei Medical Technology Co ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Zhejiang Taimei Medical Technology Co's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was 0.00%.

As of today (2025-04-06), Zhejiang Taimei Medical Technology Co's WACC % is 9.92%. Zhejiang Taimei Medical Technology Co's ROIC % is -99.09% (calculated using TTM income statement data). Zhejiang Taimei Medical Technology Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Zhejiang Taimei Medical Technology Co ROIC % Historical Data

The historical data trend for Zhejiang Taimei Medical Technology Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Taimei Medical Technology Co ROIC % Chart

Zhejiang Taimei Medical Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
ROIC %
-119.09 -123.32 -118.05 -99.09

Zhejiang Taimei Medical Technology Co Semi-Annual Data
Dec21 Dec22 Dec23 Dec24
ROIC % - - - -112.81

Competitive Comparison of Zhejiang Taimei Medical Technology Co's ROIC %

For the Health Information Services subindustry, Zhejiang Taimei Medical Technology Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Taimei Medical Technology Co's ROIC % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Zhejiang Taimei Medical Technology Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Zhejiang Taimei Medical Technology Co's ROIC % falls into.


;
;

Zhejiang Taimei Medical Technology Co ROIC % Calculation

Zhejiang Taimei Medical Technology Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-411.134 * ( 1 - -0% )/( (390.694 + 305.829)/ 2 )
=-411.134/348.2615
=-118.05 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2038.34 - 231.346 - ( 1572.136 - max(0, 437.118 - 1853.418+1572.136))
=390.694

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1580.152 - 215.192 - ( 1168.137 - max(0, 391.43 - 1450.561+1168.137))
=305.829

Zhejiang Taimei Medical Technology Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=0 * ( 1 - 0% )/( (390.694 + 305.829)/ 2 )
=0/348.2615
=0.00 %

where

Invested Capital(Q: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2038.34 - 231.346 - ( 1572.136 - max(0, 437.118 - 1853.418+1572.136))
=390.694

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1580.152 - 215.192 - ( 1168.137 - max(0, 391.43 - 1450.561+1168.137))
=305.829

Note: The Operating Income data used here is one times the annual (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Taimei Medical Technology Co  (HKSE:02576) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Zhejiang Taimei Medical Technology Co's WACC % is 9.92%. Zhejiang Taimei Medical Technology Co's ROIC % is -99.09% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Zhejiang Taimei Medical Technology Co ROIC % Related Terms

Thank you for viewing the detailed overview of Zhejiang Taimei Medical Technology Co's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Taimei Medical Technology Co Business Description

Traded in Other Exchanges
N/A
Address
36 Changsheng South Road, 3rd Floor, Building 9, Smart Industry Innovation Park, Zhejiang, Jiaxing, CHN
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China, It designs and delivers industry-specific software and digital services that facilitate the research and development (R&D) as well as the commercialization of pharmaceuticals and medical devices. The software It offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. These cloud-based software covers critical use cases in R&D and commercialization of innovative drugs and medical devices.
Executives
Zuo Lingye 2201 Interest of corporation controlled by you
Shang Hai Jing Wei Gu Quan Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Hang Zhou Jing Wei Yuan Chuang Tou Zi Guan Li He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Jing Wei Chuang Teng Hang Zhou Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Shen Zhen Shi Teng Xun Rui Tou Qi Ye Guan Li You Xian Gong Si
Teng Xun Ke Ji Shen Zhen You Xian Gong Si
Chen Yihai 2202 Interest of your spouse
Shang Hai Chen Xi Chuang Ye Tou Zi Zhong Xin You Xian He Huo 2101 Beneficial owner
Shang Hai Yuan Pan Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Xue Qiong 2201 Interest of corporation controlled by you
Ma Huateng
Lin Zhi Teng Xun Tou Zi Guan Li You Xian Gong Si
Shen Zhen Shi Teng Xun Chan Ye Tou Zi Ji Jin You Xian Gong Si
Oriental Power Holdings Limited
Shen Zhen Shi Teng Xun Rui Jian Tou Zi You Xian Gong Si

Zhejiang Taimei Medical Technology Co Headlines

No Headlines